Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy.

Narita I, Goto S, Saito N, Song J, Omori K, Kondo D, Sakatsume M, Gejyo F.

Kidney Int. 2003 Sep;64(3):1050-8.

2.

[Gene polymorphisms of renin-angiotensin system in patients with kidney diseases].

Narita I, Gejyo F.

Nihon Rinsho. 2004 Oct;62(10):1811-5. Review. Japanese.

PMID:
15500123
3.

The renin--angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy.

Ong-Ajyooth S, Ong-Ajyooth L, Limmongkon A, Tiensingh A, Parichatikanon P, Nilwarangkur S.

J Med Assoc Thai. 1999 Jul;82(7):681-9.

PMID:
10511770
4.

Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients.

Pei Y, Scholey J, Thai K, Suzuki M, Cattran D.

J Clin Invest. 1997 Aug 15;100(4):814-20.

5.

Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men.

Frimat L, Philippe C, Maghakian MN, Jonveaux P, Hurault de Ligny B, Guillemin F, Kessler M.

J Am Soc Nephrol. 2000 Nov;11(11):2062-7.

6.

A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy.

Goto S, Narita I, Saito N, Watanabe Y, Yamazaki H, Sakatsume M, Shimada H, Nishi S, Ueno M, Akazawa K, Arakawa M, Gejyo F.

Kidney Int. 2002 Sep;62(3):980-5. Erratum in: Kidney Int. 2003 Jan;63(1):400.

7.

Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients.

Narita I, Goto S, Saito N, Song J, Ajiro J, Sato F, Saga D, Kondo D, Akazawa K, Sakatsume M, Gejyo F.

Hypertension. 2003 Sep;42(3):304-9. Epub 2003 Jul 28.

PMID:
12885793
8.

ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy.

Teranishi J, Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Okada N, Moriyama T, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y.

J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):633-41. doi: 10.1177/1470320313515036. Epub 2014 Jan 22.

PMID:
24452035
9.

Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.

Zhu X, Kong D, Zhang L, Sun Y, Na S, Han C, Jin X.

Hum Pathol. 2013 Dec;44(12):2806-13. doi: 10.1016/j.humpath.2013.07.032. Epub 2013 Oct 21.

PMID:
24157068
10.

Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.

Urushihara M, Nagai T, Kinoshita Y, Nishiyama S, Suga K, Ozaki N, Jamba A, Kondo S, Kobori H, Kagami S.

Pediatr Nephrol. 2015 Jun;30(6):975-82. doi: 10.1007/s00467-014-3028-8. Epub 2014 Dec 20.

11.

Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy.

Maruyama K, Yoshida M, Nishio H, Shirakawa T, Kawamura T, Tanaka R, Nakamura H, Iijima K, Yoshikawa N.

Pediatr Nephrol. 2001 Apr;16(4):350-5.

PMID:
11354780
12.

ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.

Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Bhansali A, Sud K, Khullar M.

DNA Cell Biol. 2009 Mar;28(3):141-50. doi: 10.1089/dna.2008.0810.

PMID:
19108684
13.

Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.

Hunley TE, Julian BA, Phillips JA 3rd, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V.

Kidney Int. 1996 Feb;49(2):571-7.

14.

Influence of genetic polymorphisms of the renin-angiotensin system on IgA nephropathy.

Bantis C, Ivens K, Kreusser W, Koch M, Klein-Vehne N, Grabensee B, Heering P.

Am J Nephrol. 2004 Mar-Apr;24(2):258-67. Epub 2004 Mar 17.

PMID:
15031629
15.
16.

Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.

Lovati E, Richard A, Frey BM, Frey FJ, Ferrari P.

Kidney Int. 2001 Jul;60(1):46-54.

17.

Polymorphism of renin-angiotensin system genes in IgA nephropathy.

Woo KT, Lau YK, Choong LH, Zhao Y, Tan HB, Fook-Chong S, Tan EK, Yap HK, Wong KS.

Nephrology (Carlton). 2004 Oct;9(5):304-9.

PMID:
15504143
18.

Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.

Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, Knol MJ, de Boer A, Grobbee DE, Geerlings MI, Heerdink ER, Klungel OH.

J Hum Hypertens. 2008 Nov;22(11):774-80. doi: 10.1038/jhh.2008.62. Epub 2008 Jun 19.

PMID:
18563171
19.
20.

Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.

Schelleman H, Klungel OH, Witteman JC, Breteler MM, Yazdanpanah M, Danser AH, Hofman A, van Duijn CM, de Boer A, Stricker BH.

Eur J Hum Genet. 2007 Apr;15(4):478-84. Epub 2007 Feb 14.

Supplemental Content

Support Center